glutathione cysteine & SYNTHESIS Codeage L Liposomal Glutathione Setria® Antioxidant -

10.1016/j.bbagen.2019.06.012 Biochim

442 Researchers have explored inhibiting -secretase (BACE1) as an alternative to -secretase inhibitors due to its higher selectivity for APP, aiming to reduce A production

This review also emphasizes advancements in experimental models, including brain organoids and transgenic animals, which serve as crucial platforms for mechanistic studies and therapeutic validation

*Correspondence: Rohit Sharma, [email protected], [email protected], Abdur Rauf, [email protected] These authors have contributed equally to this work and share first authorship This article was submitted to Neuropharmacology, a section of the journal Frontiers in Pharmacology Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers